Senior Research Associate at CSL Behring
Berlin, Berlin, Germany -
Full Time


Start Date

Immediate

Expiry Date

29 Jan, 27

Salary

45000.0

Posted On

31 Oct, 26

Experience

3 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

No

Skills

Industry

Pharmaceutical & Personal Care Products

Description
  1. ·      Spearhead ADME (Absorption, Distribution, Metabolism, Excretion) studies to support early-stage drug discovery projects.
  2. ·      Develop and optimise in-vitro assays, including metabolic stability, enzyme phenotyping, and drug-drug interaction studies.
  3. ·      Conduct high-throughput screening using liver microsomes, S9 fractions, and recombinant CYPs for compound profiling.
  4. ·      Analyse pharmacokinetic parameters (NCA) and provide actionable insights for candidate selection.
  5. ·      Develop and optimise LC-MS/MS methods for the quantification of small molecules and metabolites.
  6. ·      Maintain rigorous documentation and compliance with GLP standards.
  7. ·      Conducted rodent and non-rodent pharmacokinetic studies, supporting in vitro-to-in vivo translation (IVIVC) for early candidate selection.
  8. Validated and developed time-dependent inhibition (TDI) assays (IC₅ shift method), glucuronidation and sulfation studies using S9 fractions and microsomes, contributing to expanded laboratory capabilities
Responsibilities

·      Spearhead ADME (Absorption, Distribution, Metabolism, Excretion) studies to support early-stage drug discovery projects.

·      Develop and optimise in-vitro assays, including metabolic stability, enzyme phenotyping, and drug-drug interaction studies.

·      Conduct high-throughput screening using liver microsomes, S9 fractions, and recombinant CYPs for compound profiling.

·      Analyse pharmacokinetic parameters (NCA) and provide actionable insights for candidate selection.

·      Develop and optimise LC-MS/MS methods for the quantification of small molecules and metabolites.

·      Maintain rigorous documentation and compliance with GLP standards.

·      Conducted rodent and non-rodent pharmacokinetic studies, supporting in vitro-to-in vivo translation (IVIVC) for early candidate selection.

Validated and developed time-dependent inhibition (TDI) assays (IC₅ shift method), glucuronidation and sulfation studies using S9 fractions and microsomes, contributing to expanded laboratory capabilities

Loading...